A biomarker (short for biological marker) is a measurable indicator of a biological process, physiological state, or pathological condition. Biomarkers can be molecules such as DNA, RNA, proteins, metabolites, or even cellular traits, and are typically used to detect or monitor disease, assess treatment response, or predict therapeutic outcomes.
As a dedicated biomarker service provider, our company specializes in advancing translational research to support innovative drug development. We offer a comprehensive, end-to-end platform that integrates multi-omics technologies and high-precision analytical methods. Our goal is to enable pharmaceutical companies and research institutions to efficiently progress from biomarker discovery and validation to clinical translation. By combining state-of-the-art approaches such as genomics, proteomics, and flow cytometry, we empower clients to uncover novel drug targets, elucidate mechanisms of action, stratify patient populations, and predict therapeutic responses with scientific rigor and accuracy.
Our Services
We provide a full suite of biomarker-related services to support various stages of translational research:
What We Enable
Our biomarker and translational research services are designed to drive innovation across the full spectrum of drug discovery and development. By applying advanced technologies and validated methodologies, we enable clients to address critical scientific and clinical challenges. The key applications of our services include:
Through integrated genomic and proteomic analyses, we help identify and validate novel molecular targets that are essential for developing first-in-class and best-in-class therapeutics.
- Mechanism of Action (MoA) Studies
Our multi-omics platform, including flow cytometry and IHC, enables detailed characterization of drug effects at molecular and cellular levels, supporting robust MoA elucidation.
We provide insights into patient heterogeneity by identifying predictive biomarkers, which allows for the selection of subpopulations most likely to benefit from specific therapies—critical for precision medicine.
- Efficacy and Safety Biomarker Development
Our services support the discovery and validation of biomarkers that indicate therapeutic efficacy or early signs of toxicity, enabling adaptive clinical trial designs and improved decision-making.
- Companion Diagnostics Development
We assist in the co-development of biomarkers and diagnostics to accompany new therapies, enhancing regulatory success and personalized treatment strategies.
Platform Advantages
- Expert Research Team: Our multidisciplinary team brings extensive experience in molecular biology, bioinformatics, and clinical research, ensuring scientific precision and innovation.
- Advanced Instrumentation & Multi-Technology Integration: Equipped with cutting-edge platforms that support multi-layered biomarker analysis across genomic, proteomic, and cellular dimensions.
- Seamless Integration of Preclinical and Clinical Research: Our platform bridges the gap between bench and bedside, enabling smooth translation of laboratory discoveries into clinical utility.
- Innovative Collaboration Models: We offer flexible and tailored cooperation models, fostering long-term partnerships with pharmaceutical companies, biotech firms, and academic institutions.
By combining deep scientific expertise with advanced technologies, we help biopharma partners de-risk R&D, enhance clinical trial success, and bring targeted therapies to patients faster.
Let's accelerate your biomarker strategy—contact us today!
Trust Us for Your Biomarker and Translational Research Needs.
Our company offers comprehensive biomarker and translational research services to support a wide range of research and development efforts in the pharmaceutical, biotechnology, materials science and chemical industries.
Please kindly note that our products and services are for research use only.
